National Gypsum Co.

Company History & Gold Bond Joint Compound

National Gypsum Company was founded in the early twentieth century and grew into one of the largest gypsum product manufacturers in the United States. Headquartered for much of its history in the Buffalo, New York area, the company built its commercial identity around the Gold Bond brand — a name that became synonymous with wallboard, joint compound, plaster, and acoustic ceiling products throughout the postwar construction boom.

The Gold Bond brand's rise tracked almost perfectly with the explosion of residential and commercial construction that followed World War II. As millions of American homes, schools, hospitals, and office buildings went up during the 1950s and 1960s, drywall displaced traditional lath-and-plaster as the interior finish of choice. Gold Bond wallboard and joint compound were staples on construction sites from coast to coast. By the mid-1960s, National Gypsum was operating manufacturing plants in multiple states and distributing Gold Bond products nationally through a network of building-supply dealers and contractors.

At the core of Gold Bond joint compound's commercial success was its workability. The product spread smoothly, feathered well at the edges, and sanded to a fine finish — characteristics that made it a preferred brand among drywall finishers. What professional applicators did not know, and what National Gypsum did not tell them, was that the compound's desirable handling properties were partly achieved through the addition of chrysotile asbestos fiber. Internal company documents later produced in litigation revealed that Gold Bond all-purpose joint compound contained chrysotile asbestos at concentrations ranging from roughly 8 percent to as high as 15 percent by weight depending on the formulation and year of manufacture.

Chrysotile, the curly or serpentine variety of asbestos, was selected because its fine fibers acted as a reinforcing matrix within the compound, reducing cracking during drying and improving adhesion. The same physical properties that made chrysotile useful in joint compound — its fine diameter and tendency to fracture into even finer fibrils — also made it exceptionally dangerous when released into the air during the sanding process. Every time a drywall finisher abraded a dried Gold Bond surface to smooth a seam or a corner bead, those chrysotile fibers were liberated as airborne dust.

National Gypsum was not alone in using asbestos in joint compound — several other manufacturers did the same — but Gold Bond's market dominance meant that more American workers were exposed to its asbestos-containing products than perhaps any other single brand. The company also produced acoustical ceiling texture products under the Gold Bond name that contained asbestos, extending the exposure risk to plasterers and painters who sprayed or troweled those materials overhead.

By the early 1970s, the Occupational Safety and Health Administration had begun promulgating asbestos exposure limits, and the scientific and legal landscape around asbestos liability was shifting rapidly. National Gypsum and its competitors began reformulating their joint compounds, removing asbestos and substituting alternative fibers and thickeners. Gold Bond joint compound with asbestos had largely been phased out of production by 1977 to 1978. However, the product had an extended shelf life and continued to move through the distribution chain for some time after production ceased. Workers who applied or sanded existing supplies of asbestos-containing Gold Bond on construction sites in the late 1970s and even into the early 1980s could still have been exposed to products manufactured years earlier.

By the mid-1980s, asbestos personal injury lawsuits against National Gypsum were mounting rapidly. Drywall finishers and construction workers diagnosed with mesothelioma — the rare, aggressive cancer of the lining of the lung caused almost exclusively by asbestos exposure — began naming the company in litigation. The sheer volume of potential claimants, combined with the company's finite insurance coverage, made the liability unsustainable. In 1990, National Gypsum Company filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the Northern District of Texas.

The bankruptcy reorganization took several years to complete. The plan of reorganization, confirmed in 1993, created a new reorganized entity — the current National Gypsum Company — which continues to operate today, manufacturing Gold Bond products (now asbestos-free) from its Charlotte, North Carolina headquarters. Separately, the plan established the NGC Bodily Injury Trust to handle all asbestos-related personal injury claims against the former company. The trust became the exclusive remedy for individuals harmed by National Gypsum asbestos products, channeling claims away from the reorganized company and into a dedicated compensation fund.

Gold Bond Products & Asbestos Exposure

National Gypsum manufactured and sold a range of building products under the Gold Bond name. The products listed below have been identified in litigation records, company documents, and industrial hygiene studies as having contained asbestos during the periods indicated. Workers who regularly applied or sanded these products, as well as bystanders working in the same areas, faced meaningful asbestos exposure.

It is important to note that not every Gold Bond product in every year contained asbestos. Formulations changed over time, and different plants may have used slightly different recipes. However, because the chrysotile-containing formulations were widely distributed and sold under the same brand name without prominent warning labels, workers had no reliable way to know whether the specific bag or bucket of Gold Bond compound they were using contained asbestos. For legal purposes, any worker who routinely used Gold Bond joint compound or similar products from roughly 1950 through the late 1970s should be evaluated for potential asbestos exposure.

National Gypsum Manufacturing Facilities

National Gypsum operated a network of gypsum quarrying, processing, and manufacturing facilities across the United States. Workers at these plants faced occupational asbestos exposure both from the raw chrysotile fiber delivered to the plants for incorporation into joint compound and from the finished products themselves. Plant workers who handled raw asbestos bales, operated mixing equipment, or worked in areas where airborne fiber concentrations were elevated were at significant risk. The facilities below represent sites identified in litigation records and company disclosures.

Drywall Finisher Exposure — The Hidden Epidemic

For decades, mesothelioma was understood primarily as a disease of shipyard workers, pipe insulators, and industrial boilermakers — men who had handled raw asbestos insulation with their bare hands. What epidemiologists began to recognize in the 1980s and confirmed through extensive research in the 1990s and 2000s was that drywall finishing workers constituted a second major epidemic of asbestos-related disease, one that unfolded more slowly and quietly than the shipyard catastrophe but was no less real in its human toll.

The mechanism of exposure for drywall finishers is unique and particularly insidious. When chrysotile asbestos is incorporated into joint compound and that compound is applied to a drywall surface, it dries into a rigid matrix. The asbestos fibers are relatively stable in the dried state. But when a finisher takes a sanding screen or sandpaper to that surface to smooth a tape seam, feather an outside corner, or blend a patch into surrounding wall, the mechanical abrasion fractures the dried compound into particles — and the chrysotile fibers are released into the ambient air.

What makes this exposure particularly dangerous is the physics of the dust itself. Industrial hygiene studies conducted at actual job sites in the 1970s measured airborne asbestos fiber concentrations during drywall sanding that were startlingly high — in some cases exceeding 10 to 20 fibers per cubic centimeter of air, well above the OSHA permissible exposure limit that was then being phased in. Crucially, the dust produced by sanding dried joint compound is extremely fine. The median particle diameter is small enough to penetrate deep into the lower respiratory tract, reaching the alveoli and the pleural space — the precise anatomical location where mesothelioma originates.

Compounding the risk was the duration and intensity of exposure. A journeyman drywall finisher in the 1960s or 1970s might sand joint compound for six to eight hours a day, five or six days a week, for an entire career spanning decades. Unlike a worker who handled asbestos insulation for a single job or project, a career drywall finisher received what epidemiologists classify as a heavy cumulative dose — the product of high fiber concentrations multiplied by years of sustained exposure. It is now well established in occupational medicine that there is no safe level of asbestos exposure, but cumulative dose is strongly correlated with mesothelioma risk, and drywall finishers' cumulative doses were substantial.

Several peer-reviewed epidemiological studies have documented elevated mesothelioma risk among drywall finishing workers. A landmark study by Welch and colleagues published in the American Journal of Industrial Medicine analyzed mesothelioma cases in construction workers and found that drywall tapers and finishers had significantly elevated standardized mortality ratios for pleural mesothelioma compared to the general population. A study by Borak and colleagues, also published in peer-reviewed literature, examined fiber release during joint compound sanding and found that both chrysotile and, in some cases, tremolite contaminant fibers were released in concentrations capable of producing disease over a working lifetime.

The tragedy of the drywall finisher epidemic is its latency. Mesothelioma typically does not manifest clinically until 20 to 50 years after initial asbestos exposure. A worker who began a career sanding Gold Bond joint compound in 1965 might not receive a mesothelioma diagnosis until 2005 or 2015. By then, the connection between their disease and their occupational asbestos exposure might not be immediately apparent to the treating physician — particularly if the worker had also smoked, which can complicate attribution — or the worker might not associate their decades-old trade work with their current illness.

Bystander exposure among workers in adjacent trades was also significant and is now well-recognized in asbestos litigation. Carpenters hanging doors and trim, painters priming newly finished walls, electricians rough-wiring in the same spaces where drywall finishers were sanding — all of these workers inhaled the same asbestos-laden dust. Construction site ventilation in the 1960s and 1970s was often poor, and airborne fibers from one subcontractor's work could linger for hours, exposing workers who never touched a bag of Gold Bond joint compound in their lives.

Homeowners represent a third, often overlooked, exposure group. Gold Bond joint compound was sold at hardware stores and building-supply dealers for do-it-yourself use. Homeowners who installed drywall additions, paneled basements, or patched walls using Gold Bond products from the 1960s and 1970s sanded the same asbestos-containing compound without any occupational health training, respiratory protection, or awareness of the hazard. Some of these individuals have since developed mesothelioma and are eligible to file claims against the NGC Bodily Injury Trust.

NGC Bodily Injury Trust — Compensation for Victims

The NGC Bodily Injury Trust is the legal vehicle through which individuals harmed by National Gypsum asbestos products seek compensation today. The trust was established as part of National Gypsum Company's Chapter 11 reorganization plan, which was confirmed by the bankruptcy court in 1993. Under the terms of the reorganization, all present and future asbestos-related personal injury claims against National Gypsum were channeled to the trust. The reorganized National Gypsum Company — the current corporate entity that manufactures Gold Bond products — is legally protected from asbestos liability by a permanent channeling injunction.

The trust operates under a Trust Distribution Procedures document that sets out the rules for evaluating and paying claims. Eligible diseases include mesothelioma, lung cancer, other cancers, and non-malignant conditions such as asbestosis and pleural plaques. The trust uses a scheduled value system in which each disease category is assigned a scheduled claim value, and claimants receive that value multiplied by the trust's current payment percentage.

The NGC Bodily Injury Trust's payment percentage has historically been among the highest in the asbestos trust universe. As of recent reporting, the payment percentage stands at approximately 45 percent. To put this in context: many asbestos trusts established in the late 1980s and 1990s have seen their payment percentages erode significantly over time as claim volumes exceeded initial funding projections. Some trusts now pay only 1 to 5 percent of scheduled values. The NGC trust's relative strength at 45 percent reflects prudent actuarial management and adequate initial funding relative to projected claim volumes.

For a mesothelioma claimant, the practical implications are significant. If the trust's scheduled value for mesothelioma is, for example, $200,000, a claimant with a qualifying diagnosis and documented Gold Bond exposure would receive 45 percent of that amount, or $90,000, from the NGC trust alone. Many claimants have exposure histories involving multiple manufacturers and can file claims simultaneously with multiple trusts, meaning the NGC trust distribution is often additive to recoveries from other sources.

To file a claim with the NGC Bodily Injury Trust, claimants must satisfy both a medical criterion and an exposure criterion. The medical criterion requires documentation of an asbestos-related disease, typically a pathology report (for mesothelioma), imaging studies, and a physician statement. The exposure criterion requires evidence that the claimant was exposed to asbestos-containing National Gypsum products — this can be established through the claimant's own sworn statement, co-worker affidavits, employment records showing work at sites where Gold Bond was used, or product identification testimony. Because Gold Bond joint compound was so ubiquitous on American construction sites from the 1950s through the 1970s, establishing product identification is often straightforward for career drywall finishers.

Claims must be filed through an attorney; the trust does not accept pro se submissions. Most asbestos attorneys handle trust claims on a contingency fee basis, meaning the claimant pays no out-of-pocket fees — the attorney's fee is a percentage of the recovery paid only if compensation is obtained. Given the trust's strong payment percentage and relatively clear documentation requirements, NGC trust claims are often among the most predictable and efficient components of a broader asbestos claim strategy for mesothelioma patients and their families.

The statute of limitations for asbestos trust claims is a critical concern. Unlike litigation, which is governed by state statutes of limitations, trust claim deadlines are set by the trust itself. However, state law statutes of limitations still apply to the underlying tort claim, and if a claimant misses those deadlines, they may lose their right to file. For mesothelioma diagnoses, the statute of limitations generally begins to run from the date of diagnosis or the date the claimant reasonably should have known that their disease was asbestos-related. Claimants and families should consult an asbestos attorney as soon as possible after a mesothelioma diagnosis to preserve all legal options.

Frequently Asked Questions